ArticleDiscover oncology2025

VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study.

Chengcheng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.